Table 2. Baseline lipid profile as in the summarised reports.
| Author | Baseline Total Cholesterol (mg/dl) | If prevalence, what was the definition? | Baseline HDL(mg/dl) | If prevalence, what was the definition? | Baseline LDL(mg/dl) | If prevalence, what was the definition? | Baseline Triglycerides(mg/dl) | If prevalence, what was the definition? | Baseline Other (specify) | Mean (specify) | If prevalence, what was the definition? | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Prevalence (%) | Mean (SD) | Prevalence (%) | Mean (SD) | Prevalence (%) | Mean (SD) | Prevalence (%) | Mean (SD) | Prevalence (%) | |||||||
| Lazo-Porras | 56.5 | Low HDL-cholesterol (HDL-cholesterol <40 in men and <50 in women) | 3.0 | LDL-cholesterol >160 | 4.0 | Triglycerides ≥200 | 3.0 | LDL-cholesterol >160, triglycerides ≥200 & low HDL-cholesterol | ||||||||
| 36.5 | Isolated low HDL-cholesterol | 2.0 | LDL-cholesterol >160 & triglycerides ≥200 | |||||||||||||
| 91.6 | High non-HDL-cholesterol | |||||||||||||||
| 15.0 | Low HDL-cholesterol and triglycerides ≥200 | |||||||||||||||
| 2.0 | Low HDL-cholesterol & LDL-cholesterol >160 | |||||||||||||||
| Werle | 211.6 (SD: 47.4) | 45.5 (SD: 12.6) | 139.1 (SD: 42.5) | 137.2 (SD: 65.6) | 165.4 (SD: 33.7) | ApoA-I (mg/dL) | ||||||||||
| 87.5 (SD: 21.0) | ApoB-100 (mg/dL) | |||||||||||||||
| Garcia-Palmieri | 202.4 | 152.0 | ||||||||||||||
| Crespo | 50.9 | <200 | ||||||||||||||
| 33.2 | 200-239 | |||||||||||||||
| 15.9 | ≥240 | |||||||||||||||
| Garcia-Palmieri | 202.06 | |||||||||||||||